Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: comparison with conventional and conformal radiotherapy.
OBJECTIVE
No previous studies have reported the longitudinal health-related quality of life (HRQOL) for intensity modulated radiation therapy (IMRT). We compared HRQOL after IMRT with that after conventional and after conformal radiation therapy (XRT).


METHODS
A total of 110 patients underwent XRT (34 patients underwent conventional radiation therapy and 76 underwent conformal radiation therapy) and 30 underwent IMRT for clinically localized prostate cancer between 2000 and 2002. We measured the general and disease-specific HRQOL using the Medical Outcomes Study 36-Item Health Survey and University of California, Los Angeles, Prostate Cancer Index, respectively.


RESULTS
There were no significant differences in the preoperative characteristics and HRQOL scores of the two groups. Repeated measure analyses of variance revealed significantly different patterns of alteration in several general HRQOL domains between XRT and the IMRT groups. In the urinary domain, there was no difference in the alteration patterns between the two groups. The XRT group suffered worse bowel function at 3 and 6 months than the IMRT group (P < 0.05). In the XRT group, sexual function decreased at 3 months and remained substantially lower than the baseline level. However, the IMRT group showed no significant difference from the baseline level at any of the observation periods. At 18 months the XRT group showed worse sexual function than the IMRT group.


CONCLUSIONS
The two approaches showed different longitudinal profiles regarding general and disease-specific HRQOL during the first 2 years after treatment. The IMRT approach produced little impairment in bowel and sexual function.
Namiki
Shunichi
S
Tohoku Graduate School of Medicine, Department of Urology, 1-1, Seiryomachi, Aoba-ku, Sendai 980-8574, Japan. namikin@uro.med.tohoku.ac.jp
Ishidoya
Shigeto
S
Tochigi
Tatsuo
T
Kawamura
Sadafumi
S
Kuwahara
Masaaki
M
Terai
Akito
A
Yoshimura
Koji
K
Numata
Isao
I
Satoh
Makoto
M
Saito
Seiichi
S
Takai
Yoshihiro
Y
Yamada
Shogo
S
Arai
Yoichi
Y
D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D007172:Erectile Dysfunction / Q000209:etiology; D006304:Health Status; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000523:psychology* / Q000532:radiotherapy*; D011788:Quality of Life; D020266:Radiotherapy, Conformal; D050397:Radiotherapy, Intensity-Modulated; D016896:Treatment Outcome; D014555:Urination Disorders / Q000209:etiology
D017430:Prostate-Specific Antigen